Neonatal conjunctivitis, also known as ophthalmia neonatorum, is one of the causes of severe neonatal morbidity as well as mortality in developing countries. Neonatal conjunctivitis is defined as conjunctivitis that occurs in newborns mostly during the first few days of life. Clinical signs of the disease include edema, erythema of the eyelids, and purulent discharge from the eyes. Agents of sexually transmitted diseases (STDs) such as Neisseria gonorrhoeae and Chlamydia trachomatis are some of the etiologic agents of neonatal conjunctivitis. Microorganisms that occur on the skin and in the gastrointestinal tract such as Staphylococcus aureus and Pseudomonas sp. can also cause the disease. The cause of neonatal conjunctivitis is difficult to determine.
The global neonatal conjunctivitis treatment market is expect to expand at a significant CAGR during the forecast period. Neonatal conjunctivitis leads to blindness in babies across the world. Rising prevalence of neonatal conjunctivitis in developing countries is one of the factors driving the global market during the forecast period. Surge in the prevalence of sexually transmitted diseases (STDs) is another factor likely to propel the global market during the forecast period. Factors such as poor hygiene conditions, premature deliveries, and maternal sexually transmitted infection are some of the risk factors for neonatal conjunctivitis. Lack of awareness about the treatment of the disease in developing countries and lack of coverage of medicines in these countries are some of the factors restraining the global neonatal conjunctivitis treatment market during the forecast period.
The global neonatal conjunctivitis treatment market can be segmented based on causative agent, distribution channel, and region. Based on causative agent, neonatal conjunctivitis treatment market has been divided into neonatal conjunctivitis caused by Chlamydia, neonatal conjunctivitis caused by Neisseria, neonatal conjunctivitis caused by viruses, and others. The most common cause of neonatal conjunctivitis is Chlamydia. Hence, the neonatal conjunctivitis caused by Chlamydia segment is anticipated to hold a significant share of the global neonatal conjunctivitis treatment market during the forecast period. Based on distribution channel, the global neonatal conjunctivitis treatment market has been divided into hospital pharmacies, drug stores, and online pharmacies. The hospital pharmacies segment is anticipated to the hold the largest share of the global Cellular Therapy in Oncology Pipeline market during the forecast period.
Geographically, the global neonatal conjunctivitis treatment market has been divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market for neonatal conjunctivitis. High prevalence of sexually transmitted diseases (STDs) and rise in awareness about neonatal conjunctivitis are some of the key factors driving neonatal conjunctivitis treatment market in North America. Furthermore, rise in awareness among people about ocular drug delivery systems, rise in per capita health care expenditure, increase in R&D of new drugs are fueling the market in the region. Europe is anticipated to hold the second-largest share of the global neonatal conjunctivitis treatment market from 2017 to 2025, due to rise in the incidence of gonorrhea infection in the region. Neonatal conjunctivitis treatment market in Asia Pacific is anticipated to witness rapid growth during the forecast period. Asia Pacific is a highly lucrative market for neonatal conjunctivitis treatment, due to increase in the prevalence of infections, poor hygiene conditions in developing countries, and prolonged deliveries in some of the countries in the region.
In order to acquire a significant position in neonatal conjunctivitis treatment market, key players in the global neonatal conjunctivitis treatment market have adopted strategies such as mergers and acquisitions, improvement in products, and cost-effectiveness. Some of the key players operating in the global neonatal conjunctivitis treatment market are Merck & Co. Inc., Akorn Inc., Pfizer Inc., and Bayer AG.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.